Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials.
暂无分享,去创建一个
[1] R. Grieve,et al. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. , 2010, Health economics.
[2] J. Schafer. Multiple imputation: a primer , 1999, Statistical methods in medical research.
[3] Matthew Kowgier,et al. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods , 2008, Clinical trials.
[4] Ron Goeree,et al. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning. , 2012, Journal of clinical epidemiology.
[5] Andrew R Willan,et al. Clinical decision making and the expected value of information , 2007, Clinical trials.
[6] D. Rubin. The Bayesian Bootstrap , 1981 .
[7] Roger A. Sugden,et al. Multiple Imputation for Nonresponse in Surveys , 1988 .
[8] Anthony O'Hagan,et al. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? , 2003, Health economics.
[9] A H Briggs,et al. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.
[10] A E Ades,et al. Expected Value of Sample Information Calculations in Medical Decision Modeling , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Darren McKay,et al. External cephalic version beginning at 34 weeks' gestation versus 37 weeks' gestation: a randomized multicenter trial. , 2003, American journal of obstetrics and gynecology.
[12] Albert Y. Lo,et al. A large sample study of the Bayesian bootstrap , 1987 .
[13] Andrew R Willan,et al. Accounting for between-study variation in incremental net benefit in value of information methodology. , 2012, Health economics.
[14] Andrew R Willan,et al. The value of information and optimal clinical trial design , 2005, Statistics in medicine.
[15] Andrew R Willan,et al. Optimal clinical trial design using value of information methods with imperfect implementation. , 2009, Health economics.
[16] Andrew R Willan,et al. Expected value of information and decision making in HTA. , 2007, Health economics.
[17] Gordon B. Hazen,et al. Sensitivity Analysis and the Expected Value of Perfect Information , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] Theo Stijnen,et al. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[19] Simon Eckermann,et al. The Value of Value of Information , 2012, PharmacoEconomics.
[20] A. Narayanan. Computer generation of dirichlet random vectors , 1990 .